Charlotte Becker

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2018
  2. Progressive myoclonus ataxia: Time for a new definition?

    Sterre van der Veen, Rodi Zutt, Jan Willem J. Elting, Charlotte E. Becker, Tom J. de Koning & Marina A.J. Tijssen, 2018 aug, I: Movement Disorders. 33, 8, s. 1281-1286

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. The Better Diabetes Diagnosis (BDD) study – A review of a nationwide prospective cohort study in Sweden

    M. Persson, C. Becker, H. Elding Larsson, Lernmark, G. Forsander, S. A. Ivarsson, J. Ludvigsson, U. Samuelsson, C. Marcus & A. Carlsson, 2018 jun 1, I: Diabetes Research and Clinical Practice. 140, s. 236-244 9 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  4. 2016
  5. 2014
  6. Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

    Malin Nordström, Christer Wingren, Carsten Rose, Anders Bjartell, Charlotte Becker, Hans Lilja & Carl A K Borrebaeck, 2014, I: Proteomics Clinical Applications. 8, 11-12, s. 951-962

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2012
  8. prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk.

    Ada Tosovic, Charlotte Becker, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm & Jonas Manjer, 2012, I: International Journal of Cancer. 131, 9, s. 2126-2133

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses

    David Ulmert, Andrew J. Vickers, Howard I. Scher, Charlotte Becker, Peter Iversen, David Frankel, Jens-Kristian Jensen, Tine Kold Olesen & Hans Lilja, 2012, I: Clinical Chemistry and Laboratory Medicine. 50, 11, s. 1993-1998

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2011
  11. Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels.

    Leif Bungum, Anna-Karin Jacobsson, Fredrik Rosén, Charlotte Becker, Claus Yding Andersen, Nuray Güner & Aleksander Giwercman, 2011, I: Human Reproduction. 26, s. 678-684

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2010
  13. Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females - relation to age, gonadotrophin and steroid levels

    Leif Bungum, Anna-Karin Jacobsson, F. Rosen, Charlotte Becker, C. Y. Andersen, N. Guner & Aleksander Giwercman, 2010, I: Human Reproduction. 25, s. I298-I298

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  14. C-peptide in dried blood spots.

    Jesper Johansson, Charlotte Becker, Nils Persson, Malin Fex & Carina Törn, 2010, I: Scandinavian Journal of Clinical and Laboratory Investigation. 70, s. 404-409

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Impact of Recent Screening on Predicting the Outcome of Prostate Cancer Biopsy in Men With Elevated Prostate-Specific Antigen Data From the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

    Andrew J. Vickers, Angel M. Cronin, Gunnar Aus, Carl-Gustav Pihl, Charlotte Becker, Kim Pettersson, Peter T. Scardino, Jonas Hugosson & Hans Lilja, 2010, I: Cancer. 116, 11, s. 2612-2620

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays

    Jochen M. Schwenk, Ulrika Igel, Maja Neiman, Hanno Langen, Charlotte Becker, Anders Bjartell, Fredrik Ponten, Fredrik Wiklund, Henrik Gronberg, Peter Nilsson & Mathias Uhlen, 2010, I: Molecular & Cellular Proteomics. 9, 11, s. 2497-2507

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2008
  18. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden

    Andrew J. Vickers, Angel M. Cronin, Gunnar Aus, Carl-Gustav Pihl, Charlotte Becker, Kim Pettersson, Peter T. Scardino, Jonas Hugosson & Hans Lilja, 2008, I: BMC Medicine. 6, 19.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

    David Ulmert, Angel M Cronin, Thomas Björk, Matthew F O'Brien, Peter T Scardino, James A Eastham, Charlotte Becker, Göran Berglund, Andrew J Vickers & Hans Lilja, 2008, I: BMC Medicine. 6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2007
  21. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

    Hans Lilja, David Ulmert, Thomas Björk, Charlotte Becker, Angel M Serio, Jan-Ake Nilsson, Per-Anders Abrahamsson, Andrew J Vickers & Göran Berglund, 2007, I: Journal of Clinical Oncology. 25, 4, s. 431-436

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Seminal plasma albumin: origin and relation to the male reproductive parameters.

    Saad Elzanaty, Juris Erenpreiss & Charlotte Becker, 2007, I: Andrologia. 39, 2, s. 60-65

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2006
  24. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism

    Erik Almqvist, Charlotte Becker, Anne-Greth Bondeson, Lennart Bondeson, Johan Svensson & Sven-Eric Svensson, 2006, I: Clinical Endocrinology. 65, 6, s. 760-766

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women

    Erik Almqvist, Charlotte Becker, Anne-Greth Bondeson, Lennart Bondeson & J Svensson, 2006, I: Clinical Endocrinology. 64, 1, s. 58-62

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C.

    David Ulmert, Charlotte Becker, Jan-Ake Nilsson, Timo Piironen, Thomas Björk, Jonas Hugosson, Göran Berglund & Hans Lilja, 2006, I: Clinical Chemistry. 52, 2, s. 235-239

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

    T Steuber, AJ Vickers, A Haese, Charlotte Becker, K Pettersson, FKH Chun, MW Kattan, JA Eastham, PT Scardino, H Huland & Hans Lilja, 2006, I: International Journal of Cancer. 118, 5, s. 1234-1240

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2005
  29. Thin-Film Technology for HTSC Josephson Devices

    P. Seidel, F. Schmidl, H. Wald, M. Mans, K. Peiselt, U. Baldeweg, M. Beck, S. Biering, C. Becker, Jens Uhlig & V. Grosse, 2005, I: IEEE Transactions on Applied Superconductivity. 15, 2, s. 161-164 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2004
  31. Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio

    G Aus, Charlotte Becker, S Franzen, Hans Lilja, P Lodding & J Hugosson, 2004, I: European Urology. 45, 2, s. 160-165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: A prospective and randomized study

    Erik Almqvist, Charlotte Becker, Anne-Greth Bondeson, Lennart Bondeson & J Svensson, 2004, I: Surgery. 136, 6, s. 1281-1287

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 2003
  34. Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues

    Yue Cao, Charlotte Becker, Åke Lundwall, Anders Christensson, Virgil Gadaleanu, Hans Lilja & Anders Bjartell, 2003, I: Prostate. 57, 3, s. 196-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

    G Aus, Charlotte Becker, Hans Lilja, A Khatami, CG Pihl & J Hugosson, 2003, I: Scandinavian Journal of Urology and Nephrology. 37, 6, s. 466-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.

    Charlotte Becker, Timo Piironen, Kim Pettersson, Jonas Hugosson & Hans Lilja, 2003, I: Journal of Urology. 170, 4 Pt 1, s. 1169-1174

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer

    A Haese, M Graefen, Charlotte Becker, J Noldus, J Katz, I Cagiannos, M Kattan, PT Scardino, E Huland, H Huland & Hans Lilja, 2003, I: The Prostate. 54, 3, s. 181-186

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2001
  39. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml

    Alexander Haese, Markus Graefen, Thomas Steuber, Charlotte Becker, Kim Pettersson, Timo Piironen, Joachim Noldus, Hartwig Huland & Hans Lilja, 2001, I: The Prostate. 49, 2, s. 101-109

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level

    M Tornblom, U Norming, Charlotte Becker, Hans Lilja & O Gustafsson, 2001, I: BJU International. 87, 7, s. 638-642

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 2000
  42. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum

    Charlotte Becker, T Piironen, K Pettersson, Thomas Björk, K J Wojno, J E Oesterling & Hans Lilja, 2000, I: Journal of Urology. 163, 1, s. 311-316

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer

    A Haese, Charlotte Becker, J Noldus, M Graefen, E Huland, H Huland & Hans Lilja, 2000, I: Journal of Urology. 163, 5, s. 1491-1497

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Human glandular kallikrein 2 (hK2) in prostate cancer: Clinical and Methodological studies

    Charlotte Becker, 2000, Department of Laboratory Medicine, Lund University. 126 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  45. Sensitive and specific immunodetection of human glandular kallikrein 2 in serum

    Charlotte Becker, T Piironen, J Kiviniemi, Hans Lilja & K Pettersson, 2000, I: Clinical Chemistry. 46, 2, s. 198-206

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues

    Anders Bjartell, A Paju, U H Stenman, V Vaisanen, G Aumuller, E Diamandis, Charlotte Becker & Hans Lilja, 2000, I: Prostate Cancer and Prostatic Diseases. 3, Suppl 1, s. S7-S7

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

    J Hugosson, G Aus, Charlotte Becker, S Carlsson, H Eriksson, Hans Lilja, P Lodding & G Tibblin, 2000, I: BJU International. 85, 9, s. 1078-1084

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. 1999
  49. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen

    Charlotte Becker, Ingrid Wigheden & Hans Lilja, 1999, I: Tumor Biology. 20, Suppl. 1, s. 13-17

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL

    M Tornblom, U Norming, J Adolfsson, Charlotte Becker, Per-Anders Abrahamsson, Hans Lilja & O Gustafsson, 1999, I: Urology. 53, 5, s. 945-950

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen

    U H Stenman, E Paus, W J Allard, I Andersson, C Andres, T R Barnett, Charlotte Becker, A Belenky, L Bellanger, C M Pellegrino, O P Bormer, G Davis, B Dowell, L S Grauer, D C Jette, B Karlsson, F T Kreutz, T M van der Kwast, L Lauren, M Leinimaa & 25 andra, J Leinonen, Hans Lilja, H J Linton, M Nap, O Nilsson, P C Ng, K Nustad, A Peter, K Pettersson, T Piironen, J Rapp, H G Rittenhouse, P D Rye, P Seguin, J Slota, R L Sokoloff, M R Suresh, D L Very, T J Wang, Ingrid Wigheden, R L Wolfert, K K Yeung, W-M Zhang, Z Zhou & J Hilgers, 1999, I: Tumor Biology. 20, Suppl. 1, s. 1-12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. 1998
  53. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling

    T Piironen, Bruno O Villoutreix, Charlotte Becker, K Hollingsworth, M Vihinen, D Bridon, X Qiu, J Rapp, B Dowell, T Lovgren, K Pettersson & Hans Lilja, 1998, I: Protein Science. 7, 2, s. 259-269

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. 1997
  55. Individual prostate-specific antigen (PSA) forms as prostate tumor markers

    Charlotte Becker & Hans Lilja, 1997, I: Clinica Chimica Acta. 257, 1, s. 117-132

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift